Previous Events

30 September – 2 October 2019

15th GERLI international Lipidomics meeting, Compiègne, France

16 October 2019

William Harvey Day, Barts and The London School of Medicine and Dentistry, Queen Mary University of London

Dr Romain Colas poster presentation, Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis

Dr Duco Koenis poster presentation, RvD5n-3 DPA engages GPR101 to promote the resolution of inflammatory arthritis and Escherichia coli infections

William Harvey Research Institute Annual Review 2019, 12 June 2019

Ms Kim Pistorius presenting PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function

Ms Mary Walker presenting 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis

Meeting of Minds Conference at The Royal Society, 11 June 2019
William Harvey Research Institute Ad-Hoc Seminar, 7 May 2019

The importance of LipoQuality in biological systems, Professor Makoto Arita, visiting Professor

Joint Meeting of NC-IUPHAR and the British Pharmacological Society, Paris, France , 26 – 28 April 2019
Banff Inflammation Workshop, Banff, Alberta, Canada, 24-27 January 2019

Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotctive and mediate the actions of statins in controlling inflammation

Dr Romain Colas presenting Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease

Dr Patricia Soares De Souza poster presentation of 13-Series Resolvins Mediate the Leukocyte-Platelet Actions of Atorvastatin and Pravastatin in Inflammatory Arthritis

Ms Mary Walker poster presentation of RvT4 Reduces Joint Oedema and Atherosclerosis during Inflammatory Arthritis  

The British Pharmacological Society Pharmacology 2018, London, 18-20 December 2018

Dr Patricia Soares De Souza poster presentation of Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease – 18 December, 2018, 2PM  

7th European Workshop on Lipid Mediators, Brussels, 12-14 September 2018

Dr Jesmond Dalli, giving two presentations: Profiling the resolution metabolome: considerations and methodologies and Functional Lipid Mediator Profiling in Establishing Disease Etiopathogenesis  

Dr Patricia Soares De Souza presenting the poster Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease

Ms Kim Pistorius presenting at the Young Investigator Session PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function

Ms Mary Walker presenting at the Young Investigator Session 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis

Pharmacology 2017, London, 11-13 December

Ms Kim Pistorius presenting PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function

Ms Mary Walker presenting 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis  

Bioactive Lipids in Cancer, Inflammation and Related Diseases, Puerto Vallarta, Mexico, 22-25 October 2017

Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotective and mediate the actions of statins in controlling inflammation  

UK Life Science and Medicine Summit, Beijing, September 2017

Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections?  

Eurpoean Shock Society, Paris, September 2017

Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections?  

World Congress on Inflammation, Solna, June 2017

Dr Jesmond Dalli, Immunoresolvants are regulated by the brain and control host responses to infections and tissue regeneration   

Meeting of the Minds, Royal Society, London, May 2017

Dr Jesmond Dalli, ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control  

Biochemical Society, Birmingham, January 2017

Dr Jesmond Dalli, Maresin conjugates in tissue regeneration promote the clearance of bacterial infections and are organ protective   

BSI 2016, Liverpool, December 2016

Dr Jesmond Dalli, ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control  

Physiology 2016, Dublin, July 2016

Dr Jesmond Dalli and Dr C.N. Serhan, Elucidation of Thirteen Series Resolvins that Regulate Host Responses in Infections  

William Harvey Research Institute 30th Anniversary, June 2016
LBMSDG, London, June 2016

Dr Jesmond Dalli, LC-MS/MS Based Structure Elucidation Of Novel Bioactive Mediators And Functional Lipid Mediator Profiling  

BSI London Immunology Showcase, May 2016

Dr Jesmond Dalli, Omega-3-fatty acids in inflammatory resolution and organ protection: Specialized Pro-resolving Mediators  

OARSI, Amsterdam, April 2016

Dr Jesmond Dalli, Lipid Mediators and the Resolution of Chronic Inflammation: Implications for Arthritis Therapy